Analyst Ratings for Adeptus Biotechnologies Corp. (ADPT)
ADPT Rating Summary
ADPT Price Target Summary
- Highest: $22.00 (Guggenheim)
- Lowest: $19.00 (JPMorgan)
- Average: $20.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.57 (-10.2%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
Avg. $ Target:
$20.57 (-10.2%)
* Over Last 12-Mos
Rating Score: 7.6 / 10
Percentile Rank: 80%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2025 | Morgan Stanley » Updated 7/9/2026 |
Kallum Titchmarsh | New Coverage | Equalweight (N/A) |
20.00 (18.00) |
19.66 (22.92) |
16.58% | Details |
| 9/30/2025 | Guggenheim » Updated 6/29/2026 |
Subbu Nambi | New Coverage | Buy (N/A) |
22.00 (21.00) |
13.46 (22.92) |
70.28% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
